Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH WOCKHARDT PANACEA BIOTECH/
WOCKHARDT
 
P/E (TTM) x -60.9 -16.8 - View Chart
P/BV x 0.9 2.7 32.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PANACEA BIOTECH   WOCKHARDT
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
WOCKHARDT
Mar-23
PANACEA BIOTECH/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs191316 60.6%   
Low Rs107145 73.7%   
Sales per share (Unadj.) Rs75.1184.0 40.8%  
Earnings per share (Unadj.) Rs-5.5-43.1 12.8%  
Cash flow per share (Unadj.) Rs0.9-25.7 -3.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs137.7231.7 59.5%  
Shares outstanding (eoy) m61.25144.09 42.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.3 158.7%   
Avg P/E ratio x-27.1-5.3 506.7%  
P/CF ratio (eoy) x170.0-9.0 -1,894.3%  
Price / Book Value ratio x1.11.0 108.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m9,14233,202 27.5%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2656,370 19.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59926,510 17.3%  
Other income Rs m5171,220 42.3%   
Total revenues Rs m5,11627,730 18.4%   
Gross profit Rs m47-1,930 -2.4%  
Depreciation Rs m3912,510 15.6%   
Interest Rs m443,020 1.5%   
Profit before tax Rs m128-6,240 -2.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466-30 -1,551.7%   
Profit after tax Rs m-337-6,210 5.4%  
Gross profit margin %1.0-7.3 -14.0%  
Effective tax rate %363.50.5 75,614.2%   
Net profit margin %-7.3-23.4 31.3%  
BALANCE SHEET DATA
Current assets Rs m5,62319,140 29.4%   
Current liabilities Rs m3,29734,350 9.6%   
Net working cap to sales %50.6-57.4 -88.1%  
Current ratio x1.70.6 306.1%  
Inventory Days Days5939 149.1%  
Debtors Days Days4811 434.6%  
Net fixed assets Rs m7,02848,670 14.4%   
Share capital Rs m61720 8.5%   
"Free" reserves Rs m8,37532,660 25.6%   
Net worth Rs m8,43633,380 25.3%   
Long term debt Rs m2022,240 9.0%   
Total assets Rs m12,71270,750 18.0%  
Interest coverage x3.9-1.1 -364.5%   
Debt to equity ratio x00.1 35.6%  
Sales to assets ratio x0.40.4 96.6%   
Return on assets %-2.3-4.5 51.1%  
Return on equity %-4.0-18.6 21.5%  
Return on capital %2.0-9.0 -22.1%  
Exports to sales %43.30-   
Imports to sales %24.43.5 703.9%   
Exports (fob) Rs m1,992NA-   
Imports (cif) Rs m1,124920 122.1%   
Fx inflow Rs m1,992730 272.9%   
Fx outflow Rs m1,191920 129.4%   
Net fx Rs m801-190 -421.8%   
CASH FLOW
From Operations Rs m-4,2251,530 -276.1%  
From Investments Rs m4,303-1,250 -344.3%  
From Financial Activity Rs m-184-3,150 5.8%  
Net Cashflow Rs m-105-2,800 3.7%  

Share Holding

Indian Promoters % 73.6 54.9 134.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 4.5 21.2%  
FIIs % 0.3 4.2 6.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 45.1 58.6%  
Shareholders   47,091 161,813 29.1%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs Wockhardt Share Price Performance

Period Panacea Biotech Wockhardt S&P BSE HEALTHCARE
1-Day -1.74% 4.99% 1.18%
1-Month -20.01% 0.15% -0.75%
1-Year 11.75% 290.07% 61.82%
3-Year CAGR -12.26% 13.79% 18.16%
5-Year CAGR -9.98% 7.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.